We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FARO
1501
DELISTED
Faro Technologies
FARO
$426K 0.01%
7,841
+1,055
+16% +$58.9K
RVNC
1502
DELISTED
Revance Therapeutics, Inc.
RVNC
$426K 0.01%
15,532
+4,557
+42% +$137K
ECYT
1503
DELISTED
Endocyte, Inc. Common Stock
ECYT
$426K 0.01%
+30,890
New +$367K
HURN icon
1504
Huron Consulting
HURN
$2.39B
$424K 0.01%
10,356
MRTX
1505
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$424K 0.01%
+8,594
New +$325K
MOD icon
1506
Modine Manufacturing
MOD
$10.6B
$423K 0.01%
23,187
DBD
1507
DELISTED
Diebold Nixdorf Incorporated
DBD
$423K 0.01%
35,435
-47,390
-57% -$634K
FORM icon
1508
FormFactor
FORM
$10.1B
$422K 0.01%
31,702
APPF icon
1509
AppFolio
APPF
$6.97B
$421K 0.01%
6,877
+2,800
+69% +$153K
SMCI icon
1510
Super Micro Computer
SMCI
$24.3B
$421K 0.01%
177,880
ECPG icon
1511
Encore Capital Group
ECPG
$2.07B
$420K 0.01%
11,469
GTHX
1512
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$420K 0.01%
9,655
+3,123
+48% +$134K
VSTO
1513
DELISTED
Vista Outdoor Inc.
VSTO
$419K ﹤0.01%
27,041
ALG icon
1514
Alamo Group
ALG
$2.01B
$418K ﹤0.01%
4,629
CTMX icon
1515
CytomX Therapeutics
CTMX
$760M
$418K ﹤0.01%
18,290
+4,831
+36% +$123K
CARB
1516
DELISTED
Carbonite Inc
CARB
$418K ﹤0.01%
11,965
MAGN
1517
Magnera Corp
MAGN
$443M
$417K ﹤0.01%
1,637
HTLD icon
1518
Heartland Express
HTLD
$950M
$416K ﹤0.01%
22,410
MXL icon
1519
MaxLinear
MXL
$6.74B
$416K ﹤0.01%
26,699
PETS icon
1520
PetMed Express
PETS
$43M
$416K ﹤0.01%
9,436
BATRK icon
1521
Atlanta Braves Holdings Series B
BATRK
$3.4B
$414K ﹤0.01%
16,010
VRTS icon
1522
Virtus Investment Partners
VRTS
$1.12B
$414K ﹤0.01%
3,239
CCF
1523
DELISTED
Chase Corporation
CCF
$414K ﹤0.01%
3,533
FSP
1524
Franklin Street Properties
FSP
$46.3M
$412K ﹤0.01%
48,177
CASH icon
1525
Pathward Financial
CASH
$1.78B
$411K ﹤0.01%
12,654

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.